# Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate

> **NCT01228656** · PHASE2 · SUSPENDED · sponsor: **Azidus Brasil** · enrollment: 40 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** mometasone furoate + salicylic acid
- **DRUG:** Mometasone furoate

## Key facts

- **NCT ID:** NCT01228656
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-09
- **Primary completion:** 2010-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228656, "Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01228656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*